Cost-effectiveness analysis of rheumatic heart disease prevention strategies. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

http://www.wikidata.org/entity/Q38161916

about

A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba Rheumatic heart disease among adults in a mining community of Papua, Indonesia: findings from an occupational cohort.Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.Rheumatic heart disease in Tennessee: An overlooked diagnosis.Rheumatic heart disease screening: Current concepts and challenges Rheumatic heart disease echocardiographic screening: approaching practical and affordable solutions.Child and teacher acceptability of school-based echocardiographic screening for rheumatic heart disease in Uganda.Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis.Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi-State Model.Acute rheumatic fever and rheumatic heart disease.

P2860

Q30382040-0296A928-D3F1-4635-A8AE-74DDF94BF028 Q35175210-2235C811-FBCE-46E0-B218-CE9B87597A7A Q35751957-DD37C3D7-43E5-4301-9008-1649938B7DC5 Q35835604-F049BC49-8371-4CD5-A303-AE800F62F7E9 Q36871594-4439A432-F216-4149-80C1-55F129A59A9E Q37591380-ED6DAD92-25B3-4E2C-83B4-33D73B6FABCD Q38739501-360CEBA7-F48D-4EF3-B13B-03D523A11471 Q38855361-6265A10C-2E40-4835-9D62-0D908E4C19AD Q38932245-FCD779CD-24C4-43A5-8F7F-6BF52DC8623E Q38932248-C15D3128-ABE1-41DB-97E6-D3AA12437C3F Q47429720-04F96915-82D6-4FC0-83A7-F5F03C5F7941

P2860

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

http://www.wikidata.org/entity/Q38161916

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

@en

type

label

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

@en

prefLabel

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

@en

P1433

Q38161916-3C867D49-EEE8-443C-9C36-ECB3E245C8D2

P1476

Q38161916-C851B859-DFC4-4B58-8270-FECC839B860B

P2093

Q38161916-30B81FB1-B314-45EC-B79F-94BB365C6B77

Q38161916-38B6E157-B15E-4579-A99D-0253E9A67E00

Q38161916-4944C136-5223-4578-BC41-957378D53D15

Q38161916-A42CA334-2D45-4C50-A440-9D1E4DA2FDB0

Q38161916-BC2FC3D6-09C0-42F0-A694-652AB52B59CE

Q38161916-DEED086A-682F-434A-8096-91762E36D01C

P2860

Q38161916-1C68281C-8FA2-493E-BA5B-D079CEF46EE4

Q38161916-29CA4876-62DC-4FF6-B90E-FF65ADAE45CE

Q38161916-2CB91123-B117-4F05-8B27-9BFED6C25BAC

Q38161916-4341A83D-2A7F-4252-959B-3954F0E60849

Q38161916-4693B940-021E-4A3A-9979-C2D70D051AA9

Q38161916-4E30D619-ED4B-42D6-96FF-199CA9357C8D

Q38161916-74FD9B7F-A1CD-47F2-A814-F52215802158

Q38161916-75DAC279-3088-4ADF-BDAF-713642A62F3C

Q38161916-79486851-AD3B-4BE1-8C71-B9B1C12784EE

Q38161916-7D2E586D-9AB8-41F5-8967-473E5E247455

P304

Q38161916-AA348093-128C-4A56-BD35-BAA19B617F04

P31

Q38161916-044666B1-E195-4CC3-8139-6F13330D88B3

P356

Q38161916-F38CBA5C-4B04-4C7A-AC04-B04FB9B562B4

P433

Q38161916-FA42A640-AB61-4533-B839-3CB57389E4C6

P478

Q38161916-F40F42FE-3B05-4842-A585-9121CB655F0F

P577

Q38161916-0EEA14F8-FCA5-4C90-AD4D-BB7FAA3CEBFB

P698

Q38161916-FDF02959-09E8-43E6-8C2F-2DA8BFD8BCEC

P356

14737167.2013.852470

P1433

Expert Review of Pharmacoeconomics & Outcomes Research

P1476

Cost-effectiveness analysis of rheumatic heart disease prevention strategies.

@en

P2093

Alan H Menkis

http://www.w3.org/2001/XMLSchema#string

Bram Ramjiawan

http://www.w3.org/2001/XMLSchema#string

Julia Witt

http://www.w3.org/2001/XMLSchema#string

Paramjit S Tappia

http://www.w3.org/2001/XMLSchema#string

Rizwan A Manji

http://www.w3.org/2001/XMLSchema#string

Young Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of treatment options for prevention of rheumatic heart disease from Group A streptococcal pharyngitis in a pediatric population.

Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study.

The global burden of group A streptococcal diseases.

Rheumatic heart disease.

Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren.

Prevalence of rheumatic heart disease detected by echocardiographic screening.

Rheumatic fever in children younger than 5 years: is the presentation different?

Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option.

Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease.

Acute rheumatic fever and rheumatic heart disease in indigenous populations.

P304

715-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.2013.852470

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24219047

http://www.w3.org/2001/XMLSchema#string